Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

ASSEMBLY BIOSCIENCES, INC.

ASSEMBLY BIOSCIENCES trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

ASSEMBLY BIOSCIENCES clinical trials

Registry index of 22 ClinicalTrials.gov studies linked to ASSEMBLY BIOSCIENCES programs — each row shows trial ID, program name, phase, status, and indication.

ASSEMBLY BIOSCIENCES trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for ASSEMBLY BIOSCIENCES.

  1. ABI-4334-102 — Phase 1

    Clinical update

  2. Vebicorvir (VBR) — Phase 1

    Clinical update

  3. standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI) — Phase 2

    Clinical update

  4. ABI-H2158 Reference Formulation — Phase 1

    Clinical update

  5. ABI-4334 Tablet — Phase 1

    Clinical update

  6. VBR — Phase 2

    Clinical update

  7. ABI-4334 — Phase 1

    Clinical update

  8. ABI-H2158 — Phase 1

    Clinical update

Trial registry

22 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.